Mayu Tomita

2PUBLICATIONS
5CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 27, 2025
Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma Preclinical Models.

Natsumi Kawasaki, Sei Shu, Mayu Tomita

|Aug 07, 2023
Efficacy of retreatment with polatuzumab vedotin in combination with rituximab in polatuzumab vedotin-resistant DLBCL models.

Natsumi Kawasaki, Mayu Tomita, Yoriko Yamashita-Kashima

Pageof 1

Frequent Collaborators

2 joint publications

Natsumi Kawasaki

2 joint publications

Yoriko Yamashita-Kashima

2 joint publications

Shigeki Yoshiura

1 joint publications

Sei Shu